Market Overview:
The global DNA and gene microarray market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for genotyping and gene expression applications, rising prevalence of cancer and other diseases, and technological advancements in DNA microarray platforms. The oDNA segment is expected to dominate the global DNA and gene microarray market during the forecast period owing to its high adoption for genotyping applications. However, the cDNA segment is projected to grow at a higher CAGR from 2018 to 2030 due its growing use in genome cytogenetics applications. In terms of region, North America dominates the global DNA and gene microarray market followed by Europe.
Product Definition:
DNA is a long, thin molecule that is found in the nucleus of cells. It carries the genetic information that determines how an organism looks and behaves. Gene microarray technology allows scientists to study all the genes in a cell or tissue at once. This technology can be used to identify which genes are turned on (active) and which ones are turned off (inactive). The importance of DNA and gene microarray technology is that it can help scientists understand how organisms work at a molecular level.
Oligonucleotide DNA Microarrays (oDNA):
Oligonucleotide DNA microarrays (oDNA) are short sequences of DNA, usually in the range of 10 to 100 nucleotides. Oligonucleotide probes are hybridization-specific oligonucleotides that anneal specifically to a particular sequence within a genome. They are widely used for gene expression analysis by detecting mRNA through its synthesis on the oDNA array and for protein detection via immunoprecipitation protocols.
Complementary DNA Microarrays (cDNA):
cDNA microarrays (a type of genetic microarray) are used for the detection and study of gene expression. cDNA is synthesized from the DNA extracted from a particular source such as blood, urine, or hair follicle. The array is composed of thousands of genes that can be studied simultaneously by detecting the mRNA produced from these genes using specific techniques.
Complementary DNA Microarrays (cDNA) and it's usage in DNA.
Application Insights:
Gene expression is the process by which genetic information within a cell is translated into proteins. The study of gene expression offers insights into biological processes, such as development, disease progression and treatment response in cells. Gene Expression Technology or Genome-Wide Assays (GWA) are used to measure the total amount of mRNA transcripts present in a sample. cDNA microarrays are widely used for genotyping purposes due to their ability to simultaneously assay multiple genes at once and offer high resolution compared to oligonucleotide DNA microarrays (oDNA). Other usage includes research studies that use genome-wide panels for other purposes such as drug discovery & development or forensic analysis.
The growing adoption of these technologies in research studies has fueled market growth over the past few years owing to increasing government funding for genomic projects across various universities and institutes worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of genomic research facilities and an increase in funding for genomics research. Moreover, this region is expected to grow at a lucrative rate over the forecast period owing to several initiatives taken by governments and non-profit organizations for genomic studies. For instance, Genome Canada focuses on accelerating genome sequencing projects through its core competencies that include technology development, strategic partnerships with universities and hospitals, as well as education programs & services (TDS).
Asia Pacific is anticipated to witness significant growth during the forecast period due to increasing investments from private companies along with government support for genomics R&D activities in emerging economies such as China & India. In addition, Japan has one of the largest public DNA resources available worldwide making it an ideal country for oDNA array production.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in DNA sequencing and gene expression analysis
- Growing number of research studies on DNA and gene microarrays
- Increasing funding for life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA and Gene Microarray Market Research Report
By Type
Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA)
By Application
Gene Expression, Genotyping, Other Usage, Genome Cytogenetics
By Companies
Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, BioChain, Sengenics, Applied Microarrays, US Biomax
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global DNA and Gene Microarray Market Report Segments:
The global DNA and Gene Microarray market is segmented on the basis of:
Types
Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Gene Expression, Genotyping, Other Usage, Genome Cytogenetics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- PerkinElmer
- BioChain
- Sengenics
- Applied Microarrays
- US Biomax
Highlights of The DNA and Gene Microarray Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oligonucleotide DNA Microarrays (oDNA)
- Complementary DNA Microarrays (cDNA)
- By Application:
- Gene Expression
- Genotyping
- Other Usage
- Genome Cytogenetics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA and Gene Microarray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA is a molecule that contains the genetic instructions of an organism. A gene microarray is a tool used to study the expression of genes in different tissues or cells.
Some of the major players in the dna and gene microarray market are Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, BioChain, Sengenics, Applied Microarrays, US Biomax.
The dna and gene microarray market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA and Gene Microarray Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA and Gene Microarray Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA and Gene Microarray Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA and Gene Microarray Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA and Gene Microarray Market Size & Forecast, 2020-2028
4.5.1 DNA and Gene Microarray Market Size and Y-o-Y Growth
4.5.2 DNA and Gene Microarray Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oligonucleotide DNA Microarrays (oDNA)
5.2.2 Complementary DNA Microarrays (cDNA)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Gene Expression
6.2.2 Genotyping
6.2.3 Other Usage
6.2.4 Genome Cytogenetics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA and Gene Microarray Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA and Gene Microarray Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oligonucleotide DNA Microarrays (oDNA)
9.6.2 Complementary DNA Microarrays (cDNA)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Gene Expression
9.10.2 Genotyping
9.10.3 Other Usage
9.10.4 Genome Cytogenetics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oligonucleotide DNA Microarrays (oDNA)
10.6.2 Complementary DNA Microarrays (cDNA)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Gene Expression
10.10.2 Genotyping
10.10.3 Other Usage
10.10.4 Genome Cytogenetics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oligonucleotide DNA Microarrays (oDNA)
11.6.2 Complementary DNA Microarrays (cDNA)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Gene Expression
11.10.2 Genotyping
11.10.3 Other Usage
11.10.4 Genome Cytogenetics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oligonucleotide DNA Microarrays (oDNA)
12.6.2 Complementary DNA Microarrays (cDNA)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Gene Expression
12.10.2 Genotyping
12.10.3 Other Usage
12.10.4 Genome Cytogenetics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oligonucleotide DNA Microarrays (oDNA)
13.6.2 Complementary DNA Microarrays (cDNA)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Gene Expression
13.10.2 Genotyping
13.10.3 Other Usage
13.10.4 Genome Cytogenetics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA and Gene Microarray Market: Competitive Dashboard
14.2 Global DNA and Gene Microarray Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Thermo Fisher Scientific
14.3.3 Agilent Technologies
14.3.4 Bio-Rad Laboratories
14.3.5 PerkinElmer
14.3.6 BioChain
14.3.7 Sengenics
14.3.8 Applied Microarrays
14.3.9 US Biomax
